Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDIX-101 for Chronic Bradycardia
NCT05117346Phase 2Completed
- Sponsor
- CARDIX Therapeutics LLC
- Start
- Dec 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CARDIX-101 in bradycardia, sponsored by CARDIX Therapeutics LLC. Started Dec 2022; status: completed.
02
Drugs
CARDIX-101
03
Conditions
bradycardia
Beyond the preview
Go deeper on NCT05117346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05117346.